newsfilter
← Latest News
GlobeNewswire·

Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering

MILLBRAE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. ("Eikon"), a late-stage clinical biopharmaceutical company dedicated to developing important, innovative medicines to address serious unmet